The Alzheimer's Association Medical and Scientific Advisory Group (MSAG) is composed of volunteer leaders from the Alzheimer's and dementia research community. Each of these members brings their individual perspectives and expertise to the group and serves as strategic advisors. The MSAG role was established with input and feedback from scientific volunteers, and is outlined in Knopman et al (2020) Alzheimer's & Dementia: The Journal of the Alzheimer's Association.

MSAG members bring a diversity of input to the Alzheimer’s Association for a wide range of scientific and research initiatives where the Association leads and engages. These initiatives include the Alzheimer's Association International Conference®, International Research Grant Program and Strategic Funding initiatives, Global Alzheimer's Association Interactive Network (GAAIN), International Society to Advance Alzheimer's Research and Treatment (ISTAART), Alzheimer's Association TrialMatch® clinical trial matching service, Alzheimer's Network for Treatment and Diagnostics (ALZ-NET), Association scientific journals, and diverse partnerships with researchers and research organizations around the world.

Commitment to Transparency
MSAG members acknowledge and declare all conflicts of interest, including financial, institutional and personal, that may impact their volunteer work for the Alzheimer's Association. The Alzheimer's Association collects reports of MSAG conflicts of interest on an annual basis and updates these at regular meetings throughout the year. MSAG members' respective institutions are responsible for managing their respective conflicts of interest.